Corxel touts 'competitive' ph. 2 results for oral GLP-1 asset
Corxel Pharmaceuticals reported Phase 2 results for its oral GLP-1 candidate, positioning the company for a global pivotal trial push.
Corxel Pharmaceuticals
Private
Profile of Corxel Pharmaceuticals created from news harvest. To be enriched by user.
Company Info
Sector:Clinical-stage biopharmaceuticals
Headquarters:Princeton, New Jersey, USA (with operations in Shanghai as Ji Xing Pharmaceuticals)
Founded:2019
Website:www.corxelbio.com/
Clinical Development Pipeline
Undisclosed
Target: TBDRecent News
Leadership Team
Sandy Mou
Chief Executive Officer
Careers & Job Openings